A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples